Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVernalis PLC Regulatory News (VER)

  • There is currently no data for VER

EGM Statement

30 Jun 2008 12:12

RNS Number : 8010X
Vernalis PLC
30 June 2008
 



30 June 2008

VERNALIS PLC

RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON 30 JUNE 2008

Vernalis plc announces that all resolutions proposed to shareholders at the Extraordinary General Meeting held earlier today were duly passed.

All resolutions were approved on a show of hands. The number of proxy votes received for each resolution is set out below.

Resolution

For (including discretionary votes)*

Against*

Withheld

Ordinary Resolution

1. To approve the sale by the Company of Apokyn® and the US Commercial Operations

143,094,025

(99.98%)

25,322

(0.02%)

7,576

2. To increase the Company's authorised share capital and to authorise the Directors to allot relevant securities 

143,060,249

(99.98%)

28,285

(0.02%)

38,389

Special Resolution

3. To authorise the Directors to allot equity securities for cash without application of statutory pre-emption rights

142,665,007

(99.72%)

403,407

(0.28%)

58,509

*NB: Percentage of votes cast excludes withheld votes

Vernalis has forwarded to the Document Viewing Facility of the Financial Services Authority two copies of the resolutions passed at the Extraordinary General Meeting. These copies will shortly be available for viewing at the Document Facility, at the address below, from 9.00am to 5.30pm on every weekday except bank holidays.

Document Viewing Facility

The Financial Services Authority

25 The North ColonadeCanary Wharf

London E14 5HS

Tel: 020 7066 1000

Printed copies of the resolutions may be obtained by writing to The Company Secretary, Vernalis plc, Oakdene Court, 613 reading Road, Winnersh, Berkshire RG41 5UA.

Enquiries:

Vernalis plc +44 (0)118 977 3133

Tony Weir, Chief Financial Officer

Brunswick Group +44 (0)20 7404 5959

Jon Coles

Justine McIlroy

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
EGMBDLLLVQBLBBQ
Date   Source Headline
8th Apr 20117:00 amRNSNotice of Results
16th Mar 20117:00 amRNSVernalis Initiates Phase I Trial of V158866
14th Mar 20117:00 amRNSAmericas Licensing Deal for tosedostat
28th Jan 20114:48 pmRNSHolding(s) in Company
21st Dec 20101:11 pmRNSHolding(s) in Company
16th Dec 20107:00 amRNSVernalis and H.Lundbeck A/S enter Collaboration
26th Nov 20104:40 pmRNSSecond Price Monitoring Extn
26th Nov 20104:35 pmRNSPrice Monitoring Extension
18th Nov 20107:00 amRNSInterim Management Statement
18th Nov 20107:00 amRNSVernalis plc: V3381 Programme Update
6th Oct 20107:00 amRNSVernalis and Servier Achieve Research Milestone
29th Jul 20107:00 amRNSInterim results for six months ended 30 June 2010
20th Jul 20104:44 pmRNSNotice of Interim Results
16th Jul 20107:00 amRNSPipeline update
29th Jun 20104:40 pmRNSSecond Price Monitoring Extn
29th Jun 20104:35 pmRNSPrice Monitoring Extension
9th Jun 20103:35 pmRNSHolding(s) in Company
7th Jun 20104:19 pmRNSHolding(s) in Company
4th Jun 20104:40 pmRNSSecond Price Monitoring Extn
4th Jun 20104:35 pmRNSPrice Monitoring Extension
3rd Jun 20103:22 pmRNSHolding(s) in Company
1st Jun 201012:32 pmRNSDirector/PDMR Shareholding
1st Jun 201012:26 pmRNSAGM Statement
19th May 20107:00 amRNSInterim Management Statement
17th May 20104:35 pmRNSPrice Monitoring Extension
4th May 20107:00 amRNSVernalis and Servier extend Oncology Collaboration
27th Apr 20105:16 pmRNSAnnual Information Update
27th Apr 20104:56 pmRNSAGM + Annual Report Notice
16th Apr 20101:17 pmRNSDirector/PDMR Shareholding
16th Apr 20101:16 pmRNSDirector/PDMR Shareholding
12th Apr 20107:00 amRNSAnnouncement of Results year ended 31 Dec 09
1st Apr 201010:30 amRNSNotice of Results
30th Mar 201012:56 pmRNSHolding(s) in Company
24th Mar 20107:00 amRNSIN-STEP Phase IIb study results
15th Mar 20107:00 amRNSVernalis earns milestone
8th Mar 20103:06 pmRNSVernalis Regains European Rights to Frovatriptan
5th Mar 20105:29 pmRNSHolding(s) in Company
5th Mar 20105:28 pmRNSHolding(s) in Company
5th Mar 20105:22 pmRNSHolding(s) in Company
2nd Mar 20105:49 pmRNSVoting Rights and Capital
1st Mar 201012:29 pmRNSResults of General Meeting
1st Mar 20107:00 amRNSPlacing & Open Offer Result
11th Feb 20104:20 pmRNSPublication of Prospectus
11th Feb 20107:00 amRNSPlacing and Open Offer
14th Dec 20097:00 amRNSVernalis announces clinical update
11th Dec 20097:00 amRNSVernalis Earns Milestone Payment
12th Nov 20097:00 amRNSInterim Management Statement
6th Oct 20094:40 pmRNSSecond Price Monitoring Extn
6th Oct 20094:35 pmRNSPrice Monitoring Extension
6th Oct 20097:00 amRNSInitiates Pilot Study of V3381 in Chronic Cough

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.